Clinical trial

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

NCT00898209

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2003-04-01

PhaseN/A

Study timeline

Study start (unknown)2003-04-01Date precision: month

Registry last updated2014-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

protein expression analysisGENETIC

proteomic profilingGENETIC

biologic sample preservation procedureOTHER

laboratory biomarker analysisOTHER

matrix-asst laser desorption/ionization time flight mass spectrometryOTHER

questionnaire administrationOTHER

Sponsors & collaborators

Vanderbilt-Ingram Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00898209 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.